455 related articles for article (PubMed ID: 25963141)
1. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
3. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
[TBL] [Abstract][Full Text] [Related]
4. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies.
Suzuki S; Yonekawa T; Kuwana M; Hayashi YK; Okazaki Y; Kawaguchi Y; Suzuki N; Nishino I
J Neuroimmunol; 2014 Sep; 274(1-2):202-8. PubMed ID: 25064497
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
[TBL] [Abstract][Full Text] [Related]
7. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T
Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975
[TBL] [Abstract][Full Text] [Related]
8. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
[TBL] [Abstract][Full Text] [Related]
10. [A case of chronic myopathy associated with an antibody to signal recognition particle (SRP) following long-term asymptomatic hypercreatinekinasemia].
Itaya K; Inoue M; Iwanami H; Oonaka Y; Jimi T; Ichikawa H
Rinsho Shinkeigaku; 2015; 55(4):254-8. PubMed ID: 25904255
[TBL] [Abstract][Full Text] [Related]
11. [Anti-SRP myopathy: different entity from myositis].
Suzuki S
Rinsho Shinkeigaku; 2012; 52(11):1148-50. PubMed ID: 23196545
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
Picard C; Vincent T; Lega JC; Hue S; Fortenfant F; Lakomy D; Humbel RL; Goetz J; Molinari N; Bardin N; Bertin D; Johanet C; Chretien P; Dubucquoi S; Streichenberger N; Desplat-Jégo S; Bossuyt X; Sibilia J; Abreu I; Chevailler A; Fabien N
Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256
[TBL] [Abstract][Full Text] [Related]
13. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.
De Souza FHC; Miossi R; Shinjo SK
Clin Exp Rheumatol; 2017; 35(5):766-771. PubMed ID: 28281460
[TBL] [Abstract][Full Text] [Related]
14. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.
Suzuki S; Hayashi YK; Kuwana M; Tsuburaya R; Suzuki N; Nishino I
Arch Neurol; 2012 Jun; 69(6):728-32. PubMed ID: 22332183
[TBL] [Abstract][Full Text] [Related]
15. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
Wang L; Liu L; Hao H; Gao F; Liu X; Wang Z; Zhang W; Lv H; Yuan Y
Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486
[TBL] [Abstract][Full Text] [Related]
16. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
Anquetil C; Boyer O; Wesner N; Benveniste O; Allenbach Y
Autoimmun Rev; 2019 Mar; 18(3):223-230. PubMed ID: 30639649
[TBL] [Abstract][Full Text] [Related]
17. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
Benveniste O; Drouot L; Jouen F; Charuel JL; Bloch-Queyrat C; Behin A; Amoura Z; Marie I; Guiguet M; Eymard B; Gilbert D; Tron F; Herson S; Musset L; Boyer O
Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483
[TBL] [Abstract][Full Text] [Related]
18. A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
Kawabata T; Komaki H; Saito T; Saito Y; Nakagawa E; Sugai K; Sasaki M; Hayashi YK; Nishino I; Momomura M; Kizawa T; Imagawa T; Yokota S
Brain Dev; 2012 Nov; 34(10):877-80. PubMed ID: 22436377
[TBL] [Abstract][Full Text] [Related]
19. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
[TBL] [Abstract][Full Text] [Related]
20. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
Yamaguchi T; Matsunaga A; Ikawa M; Shirafuji N; Nishino I; Hamano T
Rinsho Shinkeigaku; 2017 Mar; 57(3):118-123. PubMed ID: 28228619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
